Are resistance patterns in uropathogens published by microbiological laboratories valid for general practice?

APMIS

Volumn 107, Issue 7, 1999, Pages 676-680

  Baerheim, Anders ^a,c   Digranes, Asbjørn ^b   Hunskaar, Steinar ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Antibiotic susceptibility; General practice; Urinary tract infection

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; COTRIMOXAZOLE; MECILLINAM; NITROFURANTOIN; SULFONAMIDE; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIURIA; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; GENERAL PRACTICE; HUMAN; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS SAPROPHYTICUS; URINALYSIS; URINARY TRACT INFECTION;

EID: 0032792363     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1999.tb01458.x     Document Type: Article

References (15)

1. 1. Bergan T, Bruun JN, Digranes A, Lingaas E, Melby KK, Sander J. Susceptibility testing of bacteria and fungi. Report from "the Norwegian Working Group on Antibiotics". Scand J Infect Dis 1997;(Suppl.103):1-36.
2. 2. Baerheim A. Single-dose versus five-day treatment with trimethoprim for the acute dysuria/pyuria syndrome in women. Scand J Prim Health Care 1987;5:87-90.
3. 3. Christaens TCM, Heytens S, Verschraegen G, De Meyere M, De Maeseneer JM. Which bacteria are found in Belgian women with uncomplicated urinary tract infections in primary health care, and what is their susceptibility pattern anno 95 -96? Acta Clin Belg 1998;53:184-8.
4. 4. Ericsson HM, Sherris JC. Antibiotic sensitivity testing: Report of an international collaborative study. Acta path microbiol immunol scand Sect B 1971;79(Suppl.217):1-90.
5. 5. Ferry S, Burman LG, Holm SE. Clinical and bacteriological effects of therapy of urinary tract infection in primary health care: relation to in vitro sensitivity testing. Scand J Infect Dis 1988; 20:535-44.
6. 6. Wise R, Hart T, Cars O, Streulens M, Helmuth R, Huovinen P, Spenger M. Antimicrobial resistance. BMJ 1998;317:609-10.
7. 7. Gruneberg RN. Changes in the antibiotic sensitivities of urinary pathogens, 1971-1989. J Antimicrob Chemother 1990;26(Suppl.F):3-11.
8. 8. Porter IA, Brodie J. Boric acid preservation of urine samples. BMJ 1969;2:353-5.
9. 9. Hooton TM, Stamm WE. Management of acute uncomplicated urinary tract infection in adults. Med Clin North Am 1991;75:339-57.
10. 10. Orton P. Resistant organism: a dilemma for general care? Br J Gen Pract 1997;47:415-6.
11. 11. Straand J, Rokstad KS, Sandvik H. Prescribing systemic antibiotics in general practice. A report from the Møre & Romsdal Prescription Study. Scand J Prim Health Care 1998;16:121-7.
12. 12. Tenover FC, Hughes JM. The challenges of emerging infectious diseases. Development and spread of multiply-resistant bacterial pathogens. JAMA 1996;275:300-4.
13. 13. Trienekens T. Stobberingh E, Beckers F, Knottnerus A. The antibiotic susceptibility patterns of uropathogens isolated from general practice patients in southern Netherlands. J Antimicrob Chemother 1994;33:1064-6.
14. 14. Warren JW. Clinical presentations and epidemiology of urinary tract infections. In: Mobley HTL, Warren JW, editors. Urinary tract infections. Molecular pathogenesis and clinical management. Am Press, Washington DC 1996;3-27.
15. 15. Øydvin K, editor. Drug consumption in Norway 1992-1996. Norwegian Medicinal Depot, Oslo 1997;122-7.